Tuesday, 4 February 2025 at 11.00 – 12.00am CET (corrected from 10.00 – 11.00am CET in an earlier version of this invitation)
In connection with the publication of Coloplast’s interim financial results for Q1 2024/25, to be released same day around 07.30am CET, Coloplast will host a conference call to present the financial results and answer questions from investors and financial analysts. A presentation will be available on Coloplast’s website approximately 1 hour before the conference call.
The webcast of the conference call will be available during and after the event.
Coloplast will be represented by:
Kristian Villumsen – President & CEO
Anders Lonning-Skovgaard – Executive Vice President, CFO
Aleksandra Dimovska – Vice President, Investor Relations
Simone Dyrby Helvind – Senior Manager, Investor Relations
Webcast
For participants who do not wish to actively participate in the Q&A session, please access the conference call as a webcast via the link below:
Access the webcast here
Dial-in details
To actively participate in the Q&A session, please sign up ahead of the conference call on the link below to receive an email with dial-in details.
Register for the conference call here
For more information, please contact:
Aleksandra Dimovska – Vice President, Investor Relations
Tel.: +45 4911 1800 / direct: +45 4911 2458. E-mail: dkadim@coloplast.com
Simone Dyrby Helvind – Senior Manager, Investor Relations
Tel.: +45 4911 1800 / direct: +45 4911 2981. E-mail: dksdk@coloplast.com
Julie Isabella Sommer Müggler – Coordinator & PA, Investor Relations
Tel.: +45 4911 1800 / direct: +45 4911 3161. E-mail: dkjusm@coloplast.com
Coloplast will be available on individual phone lines after the conference call for further questions.
Attachment
Toronto, Ontario and Chicago, Illinois--(Newsfile Corp. - February 3, 2026) - Medexus Pharmaceuticals (TSX: MDP)…
GENEVA, N.Y., Feb. 3, 2026 /PRNewswire/ -- What are Employee and Employer Support Services, and…
CLINTON TOWNSHIP, Mich., Feb. 3, 2026 /PRNewswire/ -- What actually happens after your dentist takes…
LORETTO, Tenn., Feb. 3, 2026 /PRNewswire/ -- How does precision in chemical dosing affect the…
PHILADELPHIA, Feb. 3, 2026 /PRNewswire/ -- GLOBO Language Solutions, the leading B2B provider of interpreting and…
HOUSTON, Feb. 3, 2026 /PRNewswire/ -- Specialty1 Partners (S1P), the nation's fastest growing specialty dental…